BRIEF-Universal Health Q4 Adjusted EPS USD 4.92 Vs. IBES Estimate USD 4.18

Reuters

02-26

Universal Health Services Inc Cl1.56%

Feb 26 (Reuters) - Universal Health Q4 revenue USD 4,113.722 million vs. IBES estimate USD 4,010 million.

Q4 EPS USD 4.96
Q4 pretax profit USD 438.311 million vs. IBES estimate USD 368.5 million
Q4 adjusted net income USD 329.9 million vs. IBES estimate USD 278.7 million
outlook FY revenue USD 17,020-17,364 million
outlook FY adjusted EBITDA USD 2,357-2,484 million

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

no data

沒有相關數據

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2514602038"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2514602038\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2514602038?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-27 05:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2514602038","market":"nz","top_or_hot":-1,"title":"BRIEF-Universal Health Q4 Adjusted EPS USD 4.92 Vs. IBES Estimate USD 4.18","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\">\n<head>\n<meta/>\n<title>BRIEF-Universal Health Q4 Adjusted EPS USD 4.92 Vs. IBES Estimate USD 4.18</title>\n</head>\n<body>\n<p>Feb 26 (Reuters) - Universal Health Q4 revenue USD 4,113.722 million vs. IBES estimate USD 4,010 million.</p>\n<ul>\n<li>Q4 EPS USD 4.96</li>\n<li>Q4 pretax profit USD 438.311 million vs. IBES estimate USD 368.5 million</li>\n<li>Q4 adjusted net income USD 329.9 million vs. IBES estimate USD 278.7 million</li>\n<li>outlook FY revenue USD 17,020-17,364 million</li>\n<li>outlook FY adjusted EBITDA USD 2,357-2,484 million</li>\n</ul>\n</body>\n</html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Universal Health Q4 Adjusted EPS USD 4.92 Vs. IBES Estimate USD 4.18</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Universal Health Q4 Adjusted EPS USD 4.92 Vs. IBES Estimate USD 4.18\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-02-27 05:16</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\">\n<head>\n<meta/>\n<title>BRIEF-Universal Health Q4 Adjusted EPS USD 4.92 Vs. IBES Estimate USD 4.18</title>\n</head>\n<body>\n<p>Feb 26 (Reuters) - Universal Health Q4 revenue USD 4,113.722 million vs. IBES estimate USD 4,010 million.</p>\n<ul>\n<li>Q4 EPS USD 4.96</li>\n<li>Q4 pretax profit USD 438.311 million vs. IBES estimate USD 368.5 million</li>\n<li>Q4 adjusted net income USD 329.9 million vs. IBES estimate USD 278.7 million</li>\n<li>outlook FY revenue USD 17,020-17,364 million</li>\n<li>outlook FY adjusted EBITDA USD 2,357-2,484 million</li>\n</ul>\n</body>\n</html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"UHS","symbol_name":"Universal Health Services Inc Cl","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nPLXAD2661:1","article_id":"2514602038","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2514602038","pubTimestamp":1740604612,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Feb 26  - Universal Health Q4 revenue USD 4,113.722 million vs. IBES estimate USD 4,010 million.Q4 pretax profit USD 438.311 million vs. IBES estimate USD 368.5 million. Q4 adjusted net income USD 329.9 million vs. IBES estimate USD 278.7 million","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"UHS":"Universal Health Services Inc Cl"},"translate_title":"简介-Universal Health第四季度调整后每股收益为4.92美元，而IBES预估为4.18美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"UHS":0.9},"content_text":"BRIEF-Universal Health Q4 Adjusted EPS USD 4.92 Vs. IBES Estimate USD 4.18\n\n\nFeb 26 (Reuters) - Universal Health Q4 revenue USD 4,113.722 million vs. IBES estimate USD 4,010 million.\n\nQ4 EPS USD 4.96\nQ4 pretax profit USD 438.311 million vs. IBES estimate USD 368.5 million\nQ4 adjusted net income USD 329.9 million vs. IBES estimate USD 278.7 million\noutlook FY revenue USD 17,020-17,364 million\noutlook FY adjusted EBITDA USD 2,357-2,484 million","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}

如果下載按鈕點擊無跳轉，請點擊右上角菜單選擇 “在瀏覽器打開”

立即諮詢
下載APP
掃碼下載APP